Publications by authors named "Cesar Rodriguez-Sanchez"

Claim this Profile
C
Cross-Species and Tissue-Agnostic Prediction of Human Cancer Treatment Response using AI-Powered Cellular Morphometric Biomarkers from a Genetically Diverse Erbb2 Mouse Model.
Manuel J Perez-Baena, Adrian Blanco-Gomez, Alejandro Jimenez-Navas, Marta Rodriguez-Gonzalez, Maria Del Mar Abad-Hernandez, Cesar Augusto Rodriguez-Sanchez

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropogenic imprint on riverine plasmidome diversity and proliferation of antibiotic resistance genes following pollution and urbanization.
Kenia Barrantes-Jiménez, Franck Lejzerowicz, Tam Tran, Melany Calderón-Osorno, Luis Rivera-Montero

Water Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise in cancer patients: assistance levels and referral pathways-a position statement from the Spanish Society of Medical Oncology.
Blanca Herrero López, Ana Cardeña-Gutiérrez, Ana Godoy Ortiz, Ana Gonzaga López, Ana María Grueso López

Clin Transl Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characterization of pediatric acute confusional migraine: a single-center case series.
Miguel Ángel Molina Gutiérrez, Raquel Ventas Maestre, César Rodríguez Sánchez, Javier Díaz de Terán

Acta Neurol Belg· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late recurrence of lobular breast carcinoma presented as gastric metastasis.
Luis Posado-Domínguez, Luis Figuero Pérez, Laura Corvo-Felix, Pablo Díaz Sánchez, Juan Carlos Redondo-González

Rev Esp Enferm Dig· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of core lipopolysaccharide biosynthetic genes in the infection and adsorption of broad-host-range bacteriophages of Rhizobium etli.
Mary Carmen Torres-Quintero, Rosa Isela Santamaría, Irma Martínez-Flores, Patricia Bustos, Lourdes Girard

Microbiol Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union.
Lucjan Wyrwicz, César A Rodríguez Sánchez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer

Future Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence.
Marina Mendiburu-Eliçabe, Natalia García-Sancha, Roberto Corchado-Cobos, Angélica Martínez-López, Hang Chang

Clin Transl Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence.
Marina Mendiburu-Eliçabe, Natalia García-Sancha, Roberto Corchado-Cobos, Angélica Martínez-López, Hang Chang

Res Sq· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.
Aurora Gómez-Vecino, Roberto Corchado-Cobos, Adrián Blanco-Gómez, Natalia García-Sancha, Sonia Castillo-Lluva

Cells· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk.
Aurora Gómez-Vecino, Roberto Corchado-Cobos, Adrián Blanco-Gómez, Natalia García-Sancha, Sonia Castillo-Lluva

bioRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial.
Javier Salvador Bofill, Fernando Moreno Anton, Cesar Augusto Rodriguez Sanchez, Elena Galve Calvo, Cristina Hernando Melia

Breast· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.
Adrián Blanco-Gómez, Lourdes Hontecillas-Prieto, Roberto Corchado-Cobos, Natalia García-Sancha, Nélida Salvador

Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of metastatic breast cancer in Spain.
Begoña Bermejo de Las Heras, Javier Cortes Ramon Y Cajal, Elena Galve Calvo, Juan de la Haba Rodriguez, Jesus Garcia Mata

Eur J Hosp Pharm· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer.
Eugeni Lopez-Bonet, Maria Buxó, Elisabet Cuyàs, Sonia Pernas, Joan Dorca

J Clin Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.
Elisabet Cuyàs, Salvador Fernández-Arroyo, Maria Buxó, Sonia Pernas, Joan Dorca

Aging (Albany NY)· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study.
Vanesa Ortega, Antonio Antón, Isabel Garau, Noemia Afonso, Lourdes Calvo

Clin Breast Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Allele of rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin.
Elisabet Cuyàs, Maria Buxó, Maria José Ferri Iglesias, Sara Verdura, Sonia Pernas

Front Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study.
Begoña Martin-Castillo, Sonia Pernas, Joan Dorca, Isabel Álvarez, Susana Martínez

Oncotarget· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach.
Andrés Castellanos-Martín, Sonia Castillo-Lluva, María Del Mar Sáez-Freire, Adrián Blanco-Gómez, Lourdes Hontecillas-Prieto

Genome Biol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why were molecular studies not considered to classify Clostridium difficile isolates implicated in an outbreak?
Evelyn Rodríguez-Cavallini, María del Mar Gamboa Coronado, César Rodríguez Sánchez, Carlos Quesada Gómez

Rev Panam Salud Publica· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.
Agustí Barnadas, Laura G Estévez, Ana Lluch-Hernández, Alvaro Rodriguez-Lescure, César Rodriguez-Sanchez

Adv Ther· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer.
Alfonso Sánchez-Muñoz, César Mendiola, Elisabeth Pérez-Ruiz, César A Rodríguez-Sánchez, José Miguel Jurado

Oncology· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Professional survey on knowledge and clinical patterns of pain management in Spanish medical oncology.
Yolanda Escobar Álvarez, César A Rodríguez Sánchez, Fernando Caballero Martínez, Virginia Recuero Cuervo, Carlos Camps Herrero

Clin Transl Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.
Vicente Alberola Candel, Alfredo Carrato Mena, Eduardo Díaz-Rubio García, Pere Gascón Vilaplana, Manuel González Barón

Clin Transl Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis